PortfoliosLab logoPortfoliosLab logo
PAHC vs. APH
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PAHC vs. APH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Phibro Animal Health Corporation (PAHC) and Amphenol Corporation (APH). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PAHC achieves a -15.51% return, which is significantly lower than APH's 20.87% return. Over the past 10 years, PAHC has underperformed APH with an annualized return of 7.38%, while APH has yielded a comparatively higher 28.78% annualized return.


PAHC

1D
2.72%
1M
-5.31%
YTD
-15.51%
6M
-16.36%
1Y
28.20%
3Y*
35.64%
5Y*
4.58%
10Y*
7.38%

APH

1D
2.57%
1M
23.45%
YTD
20.87%
6M
18.42%
1Y
71.07%
3Y*
60.82%
5Y*
38.12%
10Y*
28.78%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PAHC vs. APH - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PAHC
Phibro Animal Health Corporation
-15.51%80.76%86.30%-10.42%-32.33%7.28%-20.09%-21.31%-3.00%15.75%
APH
Amphenol Corporation
20.87%96.08%41.30%31.85%-11.96%35.25%22.09%34.91%-6.82%31.81%

Correlation

The correlation between PAHC and APH is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.25

Correlation (3Y)
Calculated over the trailing 3-year period

0.27

Correlation (5Y)
Calculated over the trailing 5-year period

0.30

Correlation (10Y)
Calculated over the trailing 10-year period

0.30

Correlation (All Time)
Calculated using the full available price history since Apr 11, 2014

0.29

Fundamentals

Market Cap

PAHC:

$1.29B

APH:

$209.94B

EPS

PAHC:

$2.33

APH:

$4.58

PE Ratio

PAHC:

13.47

APH:

35.50

PEG Ratio

PAHC:

0.03

APH:

1.18

PS Ratio

PAHC:

0.85

APH:

8.06

PB Ratio

PAHC:

3.56

APH:

15.02

Total Revenue (TTM)

PAHC:

$1.50B

APH:

$25.90B

Gross Profit (TTM)

PAHC:

$488.12M

APH:

$9.67B

EBITDA (TTM)

PAHC:

$219.25M

APH:

$7.45B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PAHC vs. APH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PAHC
PAHC Risk / Return Rank: 5959
Overall Rank
PAHC Sharpe Ratio Rank: 6060
Sharpe Ratio Rank
PAHC Sortino Ratio Rank: 5858
Sortino Ratio Rank
PAHC Omega Ratio Rank: 6060
Omega Ratio Rank
PAHC Calmar Ratio Rank: 5656
Calmar Ratio Rank
PAHC Martin Ratio Rank: 6060
Martin Ratio Rank

APH
APH Risk / Return Rank: 8282
Overall Rank
APH Sharpe Ratio Rank: 8585
Sharpe Ratio Rank
APH Sortino Ratio Rank: 7979
Sortino Ratio Rank
APH Omega Ratio Rank: 8181
Omega Ratio Rank
APH Calmar Ratio Rank: 8181
Calmar Ratio Rank
APH Martin Ratio Rank: 8282
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PAHC vs. APH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Phibro Animal Health Corporation (PAHC) and Amphenol Corporation (APH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PAHCAPHDifference
Sharpe ratioReturn per unit of total volatility

-1.22

Sortino ratioReturn per unit of downside risk

-1.05

Omega ratioGain probability vs. loss probability

1.15

1.30

-0.14

Calmar ratioReturn relative to maximum drawdown

0.54

2.53

-1.99

Martin ratioReturn relative to average drawdown

1.59

6.52

-4.94

PAHC vs. APH - Sharpe Ratio Comparison

The current PAHC Sharpe Ratio is 0.48, which is lower than the APH Sharpe Ratio of 1.70. The chart below compares the historical Sharpe Ratios of PAHC and APH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

PAHC vs. APH - Drawdown Comparison

The maximum PAHC drawdown since its inception was -79.62%, which is greater than APH's maximum drawdown of -63.41%. Use the drawdown chart below to compare losses from any high point for PAHC and APH.


Loading charts...

Drawdown Indicators


PAHCAPHDifference

Max Drawdown

Largest peak-to-trough decline

-79.62%

-63.41%

-16.21%

Max Drawdown (1Y)

Largest decline over 1 year

-52.13%

-28.19%

-23.94%

Max Drawdown (3Y)

Largest decline over 3 years

-52.13%

-28.19%

-23.94%

Max Drawdown (5Y)

Largest decline over 5 years

-65.63%

-28.73%

-36.90%

Max Drawdown (10Y)

Largest decline over 10 years

-79.62%

-37.56%

-42.06%

Current Drawdown

Current decline from peak

-47.14%

-1.77%

-45.37%

Average Drawdown

Average peak-to-trough decline

-39.01%

-13.55%

-25.46%

Ulcer Index

Depth and duration of drawdowns from previous peaks

17.81%

10.93%

+6.88%

Volatility

PAHC vs. APH - Volatility Comparison

Phibro Animal Health Corporation (PAHC) has a higher volatility of 17.22% compared to Amphenol Corporation (APH) at 14.16%. This indicates that PAHC's price experiences larger fluctuations and is considered to be riskier than APH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PAHCAPHDifference

Volatility (1M)

Calculated over the trailing 1-month period

17.22%

14.16%

+3.06%

Volatility (6M)

Calculated over the trailing 6-month period

49.16%

36.80%

+12.36%

Volatility (1Y)

Calculated over the trailing 1-year period

58.87%

42.01%

+16.86%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

47.43%

30.88%

+16.55%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

44.61%

27.98%

+16.63%

Dividends

PAHC vs. APH - Dividend Comparison

PAHC's dividend yield for the trailing twelve months is around 1.53%, more than APH's 0.56% yield.


PositionTTM20252024202320222021202020192018201720162015
APH
Amphenol Corporation
0.56%0.55%0.79%1.07%1.06%0.89%0.80%0.89%1.09%0.80%0.86%1.01%
PAHC
Phibro Animal Health Corporation
1.53%1.28%2.29%4.15%3.58%2.35%2.47%1.93%1.31%1.19%1.37%1.33%

Financials

PAHC vs. APH - Financials Comparison

This section allows you to compare key financial metrics between Phibro Animal Health Corporation and Amphenol Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B20222023202420252026
383.54M
7.62B
(PAHC) Total Revenue
(APH) Total Revenue
Values in USD except per share items

PAHC vs. APH - Profitability Comparison

The chart below illustrates the profitability comparison between Phibro Animal Health Corporation and Amphenol Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%32.0%34.0%36.0%38.0%20222023202420252026
32.8%
36.8%
Portfolio components
PAHC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Phibro Animal Health Corporation reported a gross profit of 125.68M and revenue of 383.54M. Therefore, the gross margin over that period was 32.8%.

APH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Amphenol Corporation reported a gross profit of 2.80B and revenue of 7.62B. Therefore, the gross margin over that period was 36.8%.

PAHC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Phibro Animal Health Corporation reported an operating income of 44.65M and revenue of 383.54M, resulting in an operating margin of 11.6%.

APH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Amphenol Corporation reported an operating income of 1.83B and revenue of 7.62B, resulting in an operating margin of 24.0%.

PAHC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Phibro Animal Health Corporation reported a net income of 24.02M and revenue of 383.54M, resulting in a net margin of 6.3%.

APH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Amphenol Corporation reported a net income of 2.35B and revenue of 7.62B, resulting in a net margin of 30.8%.


Frequently Asked Questions


PAHC and APH have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PAHC has higher volatility (17.22%) compared to APH (14.16%). In terms of maximum drawdown, PAHC dropped -79.62% vs APH's -63.41%.

APH currently has the higher Sharpe Ratio (1.70 vs 0.48), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PAHC and APH

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer